M&A
DePuy Synthes adds spine implants with Expanding Innovations buy
DePuy Synthes announced on Thursday the acquisition of Expanding Innovations, a company that produces expandable implants for spinal surgery that do not require screws. The terms of the deal were not disclosed. The acquisition will strengthen DePuy's spinal portfolio and integrate with its Velys robotic platform.
Stereotaxis Completes Acquisition of Robocath
Stereotaxis has completed its acquisition of French surgical robotics company Robocath, with a total deal value of up to $45 million, including a $20 million upfront payment and up to $25 million in milestone payments. The two parties will integrate their robotics technologies in electrophysiology, interventional cardiology, and neurointervention to drive the development of next-generation systems. Robocath's R-One+ robot is already available in Europe and China, and its next-generation system is expected to be submitted for regulatory approval in the United States and Europe within two years.
Resmed sells MatrixCare business to private equity firm for $490 million
Resmed announced on Tuesday that it has reached an agreement to sell its MatrixCare long-term care software business to private equity firm Frazier Healthcare Partners for $490 million. The deal is an all-cash transaction expected to close in the first quarter of Resmed's fiscal 2027 (ending September 2026). Following the sale, Resmed will reallocate capital and resources to focus on high-growth areas such as sleep and respiratory health devices and connected home care. MatrixCare contributed approximately $220 million in revenue and $55 million in operating profit in preliminary fiscal 2026 results.